BlackRock Health Sciences Term Trust (NYSE:BMEZ) Shares Shorted: Short Interest Down 60.9% in September

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a significant decrease in short interest in the month of September. As of September 30th, there was short interest totaling 32,798 shares, a decrease of 60.9% from the September 15th total of 83,940 shares. Based on an average trading volume of 128,882 shares, the short-interest ratio is presently 0.3 days.

BlackRock Health Sciences Term Trust Trading Up 0.8%

Shares of NYSE:BMEZ traded up $0.14 during midday trading on Wednesday, hitting $16.32. The company’s stock had a trading volume of 210,196 shares, compared to its average volume of 201,906. The stock’s 50 day simple moving average is $16.57 and its 200 day simple moving average is $15.33. BlackRock Health Sciences Term Trust has a fifty-two week low of $13.70 and a fifty-two week high of $17.25.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 22nd. Stockholders of record on Friday, December 11th will be issued a dividend of $0.11 per share. The ex-dividend date is Friday, December 11th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 8.1%.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds have recently modified their holdings of the business. Integrated Wealth Concepts LLC acquired a new position in BlackRock Health Sciences Term Trust during the 2nd quarter valued at $46,000. Brown Lisle Cummings Inc. grew its position in BlackRock Health Sciences Term Trust by 7.8% in the 2nd quarter. Brown Lisle Cummings Inc. now owns 57,026 shares of the company’s stock worth $875,000 after purchasing an additional 4,108 shares during the last quarter. Corient Private Wealth LP acquired a new stake in BlackRock Health Sciences Term Trust in the 2nd quarter worth $467,000. Rivernorth Capital Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 24.8% during the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after purchasing an additional 160,629 shares during the period. Finally, Saba Capital Management L.P. bought a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth about $10,907,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a publicly traded closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total returns through a combination of current income and long-term capital appreciation by investing primarily in companies involved in the health sciences sector.

BMEZ’s investment universe includes businesses in areas such as biotechnology, pharmaceuticals, medical devices, health-care services, and life-sciences tools and equipment.